Ovid Therapeutics Inc. Contracts & Agreements

49 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
INDEMNITY AGREEMENT
Ovid Therapeutics Inc.
Biotechnology
DE
2017
Non-Employee Director Compensation Policy, effective May 5, 2022
Compensation Agreements
Ovid Therapeutics Inc.
Biotechnology
2022
License Agreement, dated as of December 30, 2021, by and between the Ovid Therapeutics Inc. and AstraZeneca AB
License Agreements
Ovid Therapeutics Inc.
2022
Non-Employee Director Compensation Policy, effective May 6, 2021
Compensation Agreements
Ovid Therapeutics Inc.
Biotechnology
2021
Amended and Restated Executive Employment Agreement between the Company and Jeffrey Rona, effective June 2, 2021
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Royalty, License and Termination Agreement, by and between the Company and Takeda Pharmaceutical Company Limited, dated March 2, 2021
Termination Agreements
Ovid Therapeutics Inc.
2021
Executive Employment Agreement between the Company and Jeff Rona, effective September 30, 2020
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Executive Employment Agreement between the Company and Jason Tardio, effective October 21, 2019
Employment Agreements
Ovid Therapeutics Inc.
2021
Amended and Restated Executive Employment Agreement between the Company and Thomas Perone, effective January 1, 2020
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020
Collaboration Agreements
Ovid Therapeutics Inc.
2021
Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020
Collaboration Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
Underwriting Agreement related to the Offering, dated August 25, 2020, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
2020
Description of the Securities of Ovid Therapeutics Inc
Ovid Therapeutics Inc.
2020
Non-Employee Director Compensation Plan
Compensation Agreements
Ovid Therapeutics Inc.
Biotechnology
2020
Second Amended and Restated Executive Employment Agreement between the Company and Amit Rakhit, effective November 1, 2019
Employment Agreements
Ovid Therapeutics Inc.
2020
Third Amended and Restated Executive Employment Agreement between the Company and Tim Daly, effective December 18, 2019
Employment Agreements
Ovid Therapeutics Inc.
2020
Underwriting Agreement related to the Common Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
2019
Underwriting Agreement related to the Preferred Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
2019
Exchange Agreement among Ovid Therapeutics Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated...
Exchange Agreements
Ovid Therapeutics Inc.
Biotechnology
2019
Lundbeck Amendment
Ovid Therapeutics Inc.
2019
Separation and Consulting Agreement, by and between the Company and Matthew During, dated as of March 24, 2019
Consulting Agreements
Ovid Therapeutics Inc.
Biotechnology
2019
Underwriting Agreement related to the Common Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Underwriting Agreement related to the Preferred Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Form of Series A Preferred Stock Certificate
Stock Agreements
Ovid Therapeutics Inc.
2019
Amended and Restated Executive Employment Agreement between the Registrant and Matthew During
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2018
Amended and Restated Executive Employment Agreement between the Registrant and Yaron Werber
Employment Agreements
Ovid Therapeutics Inc.
2018
License Agreement by and between Northwestern University and the Registrant, dated December 15, 2016
License Agreements
Ovid Therapeutics Inc.
2018
INDEMNITY AGREEMENT
Ovid Therapeutics Inc.
Biotechnology
DE
2017
LICENSE AGREEMENT BETWEEN H. LUNDBECK A/S AND OVIDTHERAPEUTICS INC.
License Agreements
Ovid Therapeutics Inc.
2017
Signature(s) Guaranteed: Medallion Guarantee Stamp
Guarantee Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
Ovid Therapeutics Inc. [] Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Ovid Therapeutics Inc.
2017
OVID THERAPEUTICS INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2017 APPROVED BYTHE STOCKHOLDERS: , 2017 IPODATE: , 2017
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
2017
OVID THERAPEUTICS INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. 2017 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:[ ] APPROVED BY THE STOCKHOLDERS:[ ]
Stock Agreements
Ovid Therapeutics Inc.
2017
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Ovid Therapeutics Inc.
2017
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Ovid Therapeutics Inc.
2017
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Ovid Therapeutics Inc.
Biotechnology
DE
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
DE
2017
AMENDMENT TO OVIDTHERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
2017
AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
2017
AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
2017
AMENDMENT TO OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK PURCHASE AGREEMENT
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT EARLY EXERCISE
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
LICENSE AGREEMENT BETWEEN H. LUNDBECK A/S AND OVIDTHERAPEUTICS INC.
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN TAKEDAPHARMACEUTICAL COMPANY LIMITED AND OVID THERAPEUTICS INC. JANUARY 6, 2017 Table of Contents
Collaboration Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
SERIES B-1 PREFERRED STOCK PURCHASE AGREEMENT TABLE OF CONTENTS
Stock Agreements
Ovid Therapeutics Inc.
2017